Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Neovascular Macular Degeneration”

505 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 505 results

Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Testing effectiveness (Phase 2)Study completedNCT05403749
What this trial is testing

Longer Interval of IVT IBI302 in Subjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 132
Large-scale testing (Phase 3)Study completedNCT02611778
What this trial is testing

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
Bioeq GmbH 712
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,118
Post-approval studies (Phase 4)Study completedNCT01775124
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 332
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Not applicableStudy completedNCT04988178
What this trial is testing

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Who this might be right for
Macular Degeneration
Brugmann University Hospital 34
Large-scale testing (Phase 3)Active Not RecruitingNCT06223958
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 344
Not applicableStudy completedNCT05066685
What this trial is testing

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 18,457
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Post-approval studies (Phase 4)Not Yet RecruitingNCT07403825
What this trial is testing

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Who this might be right for
Macular Degeneration, Age Related
Biobizkaia Health Research Institute 100
Large-scale testing (Phase 3)UnknownNCT05297292
What this trial is testing

Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Who this might be right for
Wet Age-related Macular Degeneration
Mabwell (Shanghai) Bioscience Co., Ltd. 433
Early research (Phase 1)WithdrawnNCT01177644
What this trial is testing

Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Forsight Vision4
Early research (Phase 1)Study completedNCT02591914
What this trial is testing

An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Retinal Consultants of Arizona 30
Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Testing effectiveness (Phase 2)UnknownNCT00745511
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Ora Bio Ltd. 96
Not applicableStudy completedNCT01712035
What this trial is testing

Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Oregon Health and Science University 44
Post-approval studies (Phase 4)Ended earlyNCT04287348
What this trial is testing

Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 16
Early research (Phase 1)Study completedNCT00536016
What this trial is testing

Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Who this might be right for
Macular Degeneration
Jerini Ophthalmic 36
Load More Results